1. IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?

   • Shubham Atal
   • Zeenat Fatima

   Current Opinion 13 June 2020 Pages: 223 - 231

   

2. The NIMH ‘Fast-Fail Trials’ (FAST) Initiative: Rationale, Promise, and Progress

   • Margaret C. Grabb
   • Mi Hillefors
   • William Z. Potter

   Leading Article 23 July 2020 Pages: 233 - 245

   

3. Evolving Communication with Healthcare Professionals in the Pharmaceutical Space: Current Trends and Future Perspectives

   • Andriy Krendyukov
   • Dévi Nasy

   Review Article 15 June 2020 Pages: 247 - 256

   

4. Is Psoriasis Treatment a Risk Factor for Inflammatory Bowel Disease?

   • Piotr Nehring
   • Adam Przybyłkowski

   Review Article Open access 08 June 2020 Pages: 257 - 262

5. Using Data from the Canadian Post-marketing Spontaneous Pharmacovigilance System for Drug Safety Research: A Feasibility Study

   • Samuel Akinola
   • Carolina Galli da Silveira
   • Jacinthe Leclerc

   Original Research Article 15 July 2020 Pages: 263 - 269

   

6. Patent Cliffs in the Era of Complex Therapies and Biologics

   • Marco T. Sabatini
   • Miguel Silva

   Original Research Article 09 August 2020 Pages: 271 - 278

   

7. Forum

   Update 29 July 2020 Pages: 279 - 290

8. Major Pharmaceutical Conferences and Courses

   Update 08 August 2020 Pages: 291 - 293

9. Correction to: Providing Patients with Critical or Life-Threatening Illnesses Access to Experimental Drug Therapy: A Guide to Clinical Trials and the US FDA Expanded Access Program

   • Marjorie A. Speers

   Correction 04 July 2020 Pages: 295 - 295